Dr. Regier’s CIHR-funded Catalyst project applies a mixed methods approach to enhancing shared decision-making in context to the return of genetic test results for hereditary cancer syndromes. This project addresses an unmet need for a patient centred resource that improves understanding of genetic test results and to support patients in communicating genetic risk information to potentially affected family members. Dr. Regier and members of his CCR PACER lab are collaborating closely with the BC Cancer’s Hereditary Cancer Program co-directors and patients to develop a decision support tool that is intended for feasible clinical implementation.
This combined effort will inform a more cost-effective approach to targeting primary and secondary prevention strategies to individuals and families at increased risk for hereditary cancer syndromes.